ProQR Therapeutics Income Statement (2013-2025) | PRQR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B
Operating items
Research & Development (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	0.09B	-0.01B	-0.01B	-0.01B	0.05B	-0.01B	-0.01B	-0.01B	0.07B	-0.01B	-0.01B	-0.01B	0.09B
Selling, General & Administrative (Quarter)	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.04B	-0.00B	-0.00B	-0.00B	0.03B	-0.00B	-0.00B	-0.00B	0.03B	-0.00B	-0.01B	-0.00B	0.03B
Other Operating Expenses (Quarter)	0.00				0.00		0.00					0.00			0.00	0.00	0.00
Operating Expenses (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	0.13B	-0.01B	-0.01B	-0.01B	0.08B	-0.01B	-0.01B	-0.01B	0.09B	-0.02B	-0.02B	-0.02B	0.12B
Operating Income (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
EBIT (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Non-operating items
Non Operating Investment Income (Quarter)	353.43	0.00B	-0.00B			0.00B	0.00B
Other Non Operating Income (Quarter)	477.67	-0.00B	0.00B
Non Operating Income (Quarter)	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B		-0.00B	0.00B	0.00B		0.00B	0.00B	0.00B		0.00B	0.00B	0.00B
Net income details
EBT (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Profit After Tax (Quarter)	-0.02B	0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Equity Income (Quarter)	0.00B	-0.00B	0.00B	-0.00B	-0.00B
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B
Income from Continuing Operations (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Consolidated Net Income (Quarter)	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Income towards Parent Company (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Net Income towards Common Stockholders (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Additional items
EPS (Basic) (Quarter)	-0.00B	-0.00B	-0.00B	-0.24	-0.00B	-0.00B	-0.00B	-0.16	-0.00B	-0.00B	-0.00B	-0.06	-0.00B	-0.00B	-0.00B	-2.14	-0.00B	-0.00B	-0.00B	-0.07
EPS (Weighted Average and Diluted) (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.19	-0.00B	-0.00B	-0.00B	-0.06	-0.00B	-0.00B	-0.00B	-0.11	-0.00B	-0.00B	-0.00B	-0.07
Shares Outstanding (Weighted Average) (Quarter)	301.56	578.05	825.50	0.09B	224.47	416.15	725.96	0.09B	118.07	228.67	304.81	0.09B	97.77	140.00	252.59	0.00B	105.19	237.71	374.10	0.12B
Shares Outstanding (Diluted Average) (Quarter)	301.56	578.05	825.50	0.00B	224.47	416.15	725.96	0.07B	118.07	228.67	304.81	0.09B	97.77	140.00	252.59	0.09B	105.19	237.71	374.10	0.12B
EBITDA (Quarter)	-0.01B	-0.02B	0.02B	0.02B	0.02B	0.01B	-0.02B	-0.01B	0.01B	-0.01B	0.01B	-0.01B	-0.01B	0.00B	0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.01B

Research Tools

ProQR Therapeutics Income Statement (2013-2025) | PRQR

Create an account

Sign In

Reset Password